Child Fatality in Chinese Gene Therapy Trial Amid Promising Peanut Allergy Pill Results
A child died in a gene-therapy trial in China, early studies suggest a fecal-pill could treat peanut allergy, and biotech investor Greg Verdine announced a series of recent wins.
Investigators reported a fatality involving a child participating in a gene-therapy study in China. Separate research on an oral fecal-based capsule showed encouraging outcomes for individuals with peanut allergy. Meanwhile, biotech financier Greg Verdine highlighted multiple recent achievements in his portfolio. The brief notes also mention a personal anecdote about a backyard tortoise, underscoring the newsletter's informal tone.
Why it matters
The death highlights safety concerns in gene-therapy trials, while new allergy treatments could impact many sufferers.
In this story